After METTL14 knockdown GSCs transplanted into immunodeficiency non‐obese diabetes/severe combined immunodeficiency (NOD/SCID) mice, it was found that METTL14 depletion results in significant tumor progression initiated by GSCs in the cerebra of the mice. Here, METTL14 is linked to severe combined immunodeficiency.